Browse by Hotbed/Location
Filter News
Found 514,620 articles
-
Here's a roundup of some of the top clinical trial news from the previous week.
-
Lin Huang, chief executive officer of BeyondSpring, believes her company has the “secret sauce” that could provide beneficial treatment to chemotherapy-induced neutropenia, a common side effect for chemotherapy patients.
-
An Independent Data Monitoring Committee recommended the trial be stopped because of lack of survival benefit for patients receiving the drug compared to placebo.
-
Pfizer's Fragmin was approved to reduce the recurrence of VTE in patients one month of age or older.
-
Project Facilitate is a pilot project to create a single point of contact for the FDA’s oncology expanded access requests.
-
Patients were randomized 1:1 to receive Nerlynx and Xeloda or Tykerb and Xeloda. Co-primary endpoints were progression-free survival and overall survival.
-
Some of the biggest hubs for biotech and pharma fared poorly in the rankings due to housing affordability.
-
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
-
BioSpace Movers and Shakers, May 17
5/17/2019
Biopharma companies add new leaders to executive roles and boards of directors. -
The collaboration will focus on Inovio’s VGX-3100, which stimulates a specific immune response to HPV-16 and HPV-18, targeting the infection and causing destruction of precancerous cells.
-
The company took its GSK-3B inhibitor into the clinic earlier this year. The drug is being studied in patients with refractory hematologic malignancies or solid tumors.
-
Xstrahl Spotlights New RADiant Treatment System at Texas Dermatology Society Spring Meeting in Houston
5/17/2019
Xstrahl Medical, global leader in superficial radiotherapy devices to treat non-melanoma skin cancer and dermatological conditions, is spotlighting its RADiant treatment system at the Texas Dermatology Society spring meeting on May 17th and 18th at the Marriott Marquis Hotel in Houston.
-
The Safe Epidural Protector, EpiFaith®, Announced FDA 510(k) Clearance and Global Launch Timeline
5/17/2019
Flat Medical Co., Ltd., the medtech company specializing in clinical safety solutions, announced it received 510(k) clearance from the U.S. Food and Drug Administration for its EpiFaith® syringe to deliver safe epidural locating solution.
-
Soliton Provides FDA Update and Addresses Recent Anonymous Article
5/17/2019
Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), today provided an update on its application for FDA clearance and addressed a recent anonymous article published on SeekingAlpha.com.
-
Moderna Announces Publication of Preclinical Data for Chikungunya Antibody Program
5/17/2019
Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced the publication of preclinical data in Science Immunology, showing that mRNA encoding a human monoclonal antibody against the chikungunya virus delivered in a proprietary lipid nanoparticle (LNP) can protect from infection by the virus in vivo.
-
Anheuser-Busch Recognized for Contribution to the Service to the Armed Forces Giving Program
5/17/2019
Today the American Red Cross is recognizing Anheuser-Busch Foundation for its generous commitment of $500,000 to the Red Cross Service to the Armed Forces Giving Program (SAFGP).
-
Allergan Expands PLEDGE Clinical Research Program in Diabetic Gastroparesis
5/17/2019
Allergan plc (NYSE: AGN) today announced the expansion of the PLEDGE program with a fifth study now evaluating relamorelin, an investigational, ghrelin agonist being studied for the treatment of diabetic gastroparesis (DG).
-
16-Year-Old Engineer Works to Improve Spinal Surgery Using Machine Learning and Computer Vision
5/17/2019
Krithik Ramesh, 16, of Greenwood Village, Colorado, was awarded first place for developing a machine learning technology for orthopedic surgeons at this year’s Intel International Science and Engineering Fair (ISEF), a program of Society for Science & the Public. Intel ISEF is the world’s largest international pre-college science competition.
-
MetroPlus Launches New Public Awareness Campaign: “Health Care is Your Right. Not a Privilege”
5/17/2019
As part of Mayor de Blasio’s Guaranteed Health Care for All, MetroPlus Health Plan today announced the launch of its latest public awareness campaign, “Health Care is Your Right. Not a Privilege.”
-
Arena Pharmaceuticals' Presence at Digestive Disease Week (DDW) Reinforces Commitment to the Gastrointestinal Disease Community
5/17/2019
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that it has initiated sites for its ELEVATE UC Phase 3 global program to evaluate etrasimod 2 mg in subjects with moderately to severely active ulcerative colitis (UC).